# Effect of Metformin on Biomarkers of Colorectal Tumor Cell Growth

> **NCT01632020** · PHASE2 · TERMINATED · sponsor: **University of Arkansas** · enrollment: 7 (actual)

## Conditions studied

- Colorectal Neoplasms

## Interventions

- **DRUG:** Placebo
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01632020
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-08
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Inadequate accrual
- **Last updated:** 2016-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01632020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01632020, "Effect of Metformin on Biomarkers of Colorectal Tumor Cell Growth". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01632020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*